BIO
Bio-Rad LaboratoriesCNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade C from latest DB weights. Momentum 42.1 / Value 63.6
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
42
Value
64
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $335.00
Why
Momentum42 · Δ7d +18.6
Value64 · Δ7d -0.3
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
52% active weight
Current posture
7d trendImproving
Δ7d
+18.6
Δ21d
+30.4
Value
64
48% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-1.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 42.1 / Value 63.6
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$8.23B
Beta
1.18
Shares Out
26.97M
P/E (TTM)
27.2
P/S (TTM)
3.38
P/FCF (TTM)
25.65
Rev YoY
+0.5%
EPS YoY
-154.4%
Gross Margin
+52.4%
Op Margin
+8.5%
Net Debt
-$462.9M
Current Ratio
5.44
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology